Center will reconsider the cost of COVAXIN
New Delhi, 21/6 (AO Bureau)The government may reconsider the cost of Covaxin being used in India's vaccination campaign against the coronavirus. NITI Aayog Member (Health) and Head of…
Read More...
Read More...